Sugar molecule in red meat linked with a 63% higher risk of developing type 2 diabetes in those with highest consumption
Reports and Proceedings
Updates every hour. Last Updated: 23-Oct-2026 11:17 ET (23-Oct-2026 15:17 GMT/UTC)
Preliminary results of an observational study being presented at the Annual Meeting of The European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2), reveal that a sugar called dietary N-glycolylneuraminic acid (Neu5Gc), which is common in red meat, is independently associated with a 63% higher risk of developing type 2 diabetes (T2D) in those with the highest versus lowest consumption, even after taking into account other T2D risk factors such as level of physical activity, overall diet, smoking status and other health conditions.
A treatment for pain, that is delivered via a nasal spray, offers an effective, needle-free option for children being seen in the emergency department for a range of injuries, according to research presented at the European Emergency Medicine Congress. Researchers say that reducing pain quickly and effectively is especially important for children in the emergency department, yet there are currently very few treatment options available.
Eating a diet low in ultra-processed foods (UPFs) and exercising can cut the risk of type 2 diabetes, even in those with a strong genetic disposition to the condition, new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Milan, Italy (Sept 28 – Oct 2) suggests.
The analysis of data on tens of thousands of people in the UK found that those who had a diet low in processed food and did regular moderate to vigorous physical activity were up to 70% less likely to develop the condition.
HER2-positive breast cancer accounts for about 15% of all breast cancers, and although anti-HER2 targeted therapies have dramatically improved patient survival, primary and acquired drug resistance remain major clinical challenges. In a comprehensive review, researchers from Fudan University Shanghai Cancer Center, Kunming Medical University, and collaborating institutions map ten major categories of resistance mechanisms, evaluate strategies to overcome them—including next-generation antibody-drug conjugates—and highlight predictive tools that are paving the way toward precision treatment.